Crispr Therapeutics shares tumble after significant earnings miss
On Monday, DA Davidson analyst Manuel Navas adjusted the price target for F.N.B. Corporation (NYSE:FNB) to $17.00, a decrease from the previous target of $19.00. With the stock currently trading at $12.43 and a market capitalization of $4.46 billion, the firm maintained a Buy rating. According to InvestingPro data, the stock appears slightly undervalued based on its Fair Value analysis.
F.N.B. Corporation’s first-quarter results for 2025 showcased robust pre-provision net revenue (PPNR) driven by balance sheet growth and stable credit trends. Following the earnings release, the company’s shares saw a 3% increase as it surpassed PPNR and earnings per share (EPS) expectations. InvestingPro analysis reveals the company’s strong financial health, with a "GOOD" overall rating and an impressive 51-year track record of consistent dividend payments, currently yielding 3.81%. Furthermore, F.N.B. upheld its 2025 earnings outlook, which remains unchanged despite acknowledging the uncertainties surrounding tariffs.
Navas expressed confidence in the company’s earnings potential, highlighting the neutral balance sheet positioning and the possibility for increased net interest margin (NIM) and net interest income (NII) if the tariff-related uncertainties were to resolve. He also noted the potential for growth in fees and loans. The analyst believes these factors contribute to a strong return profile for F.N.B. Corporation, which he deems is trading at an undervalued price—1.2 times tangible book value (TBV), 7.2 times estimated 2026 earnings, and 1.0 times estimated 2026 TBV—especially considering the company’s above-peer projected returns for 2026, which include a 1.8% PPNR return on assets (ROA) and a 15% return on tangible common equity (ROTCE).
Navas reiterated a Buy rating for F.N.B. Corporation, citing a 35% upside to the new price target. He maintains the EPS forecast unchanged, reflecting his positive outlook on the company’s financial performance and valuation.
In other recent news, F.N.B. Corporation reported stronger-than-expected earnings for the first quarter of 2025, with earnings per share (EPS) of $0.32, surpassing the forecasted $0.30. The company also exceeded revenue expectations, reporting $411.61 million against a predicted $410.22 million. DA Davidson maintained a Buy rating for F.N.B. Corporation, with a price target of $19.00, noting robust growth in loans and deposits alongside a slight increase in net interest income. Meanwhile, Raymond (NSE:RYMD) James adjusted the price target for F.N.B. Corporation to $15.00 from $19.00, affirming an Outperform rating due to solid first-quarter results and stable credit metrics.
Keefe, Bruyette & Woods analysts upgraded F.N.B. Corporation’s stock rating to Outperform, maintaining a price target of $16.50. They highlighted the company’s strong return on tangible common equity and potential for growth through market share gains. The analysts also noted the limited downside risk for the stock, given its current valuation levels. F.N.B. Corporation’s strategic initiatives include expanding digital banking and acquiring Raptor Partners, which are expected to contribute to the company’s diversified revenue streams. Despite macroeconomic uncertainties, the company projects mid-single-digit growth in loans and deposits for the full year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.